NEW YORK, April 18, 2016 – Sunnyvale, California-based firm InSilixa is developing an assay to test for hundreds of potential targets that confer drug resistance to Mycobacterium tuberculosis.

NEW YORK (GenomeWeb) – A new assay system for multi-drug resistant Mycobacterium tuberculosis purports to address cost and versatility issues affecting currently available TB tests.

NEW YORK (GenomeWeb) – Even with concessionary pricing and international investment, the cost of Cepheid's GeneXpert MTB/RIF for Mycobacterium tuberculosis and rifampin resistance testing sometimes strains impoverished areas.

NEW YORK (GenomeWeb) – Start-up diagnostics firm AttoDx has been awarded National Institutes of Health funds to develop an ultrasensitive molecular diagnostic for difficult-to-detect cases of tuberculosis.